Runx1t1 (Runt-related transcription factor 1; translocated to, 1) epigenetically regulates the proliferation and nitric oxide production of microglia

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Baby, Nimmi ^a   Li, Yali ^a   Ling, Eng Ang ^a   Lu, Jia ^b   Dheen, S Thameem ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DSO NATIONAL LABORATORIES   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; CYCLIN DEPENDENT KINASE 4; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; NITRIC OXIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX1T1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN DEVELOPMENT; CDK4 GENE; CELL ACTIVATION; CELL CYCLE; CELL FUNCTION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC REGULATION; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; NEUROTOXICITY; NONHUMAN; PERINATAL PERIOD; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN; BROMODEOXYURIDINE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; EPIGENESIS, GENETIC; FLUORESCENT ANTIBODY TECHNIQUE; HISTONE DEACETYLASES; MICROARRAY ANALYSIS; MICROGLIA; NITRIC OXIDE; PROTO-ONCOGENE PROTEINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84895878932     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089326     Document Type: Article

References (44)

1. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, et al. (2011) Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 70: 374-383.
2. Koshinaga M, Katayama Y, Fukushima M, Oshima H, Suma T, et al. (2000) Rapid and widespread microglial activation induced by traumatic brain injury in rat brain slices. J Neurotrauma 17: 185-192.
3. Paresce DM, Ghosh RN, Maxfield FR (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17: 553-565. (Pubitemid 26322226)
4. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P (2009) Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 210: 3-12.
5. Thomas WE (1992) Brain macrophages: evaluation of microglia and their functions. Brain Res Brain Res Rev 17: 61-74.
6. Dalmau I, Finsen B, Zimmer J, Gonzalez B, Castellano B (1998) Development of microglia in the postnatal rat hippocampus. Hippocampus 8: 458-474. (Pubitemid 28505238)
7. Dheen ST, Kaur C, Ling EA (2007) Microglial activation and its implications in the brain diseases. Curr Med Chem 14: 1189-1197. (Pubitemid 46739320)
8. Giunta B, Obregon D, Velisetty R, Sanberg PR, Borlongan CV, et al. (2012) The immunology of traumatic brain injury: a prime target for Alzheimer inverted question marks disease prevention. J Neuroinflammation 9: 185.
9. Chen XH, Johnson VE, Uryu K, Trojanowski JQ, Smith DH (2009) A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol 19: 214-223.
10. Pines J (1993) Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem Sci 18: 195-197.
11. Sherr CJ (1995) D-type cyclins. Trends Biochem Sci 20: 187-190.
12. Okumura AJ, Peterson LF, Lo MC, Zhang DE (2007) Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells. Exp Hematol 35: 978-988. (Pubitemid 46802984)
13. Davis JN, McGhee L, Meyers S (2003) The ETO (MTG8) gene family. Gene 303: 1-10. (Pubitemid 36151766)
14. Zhang J, Hug BA, Huang EY, Chen CW, Gelmetti V, et al. (2001) Oligomerization of ETO is obligatory for corepressor interaction. Mol Cell Biol 21: 156-163.
15. Zhang L, Tumer Z, Mollgard K, Barbi G, Rossier E, et al. (2009) Characterization of a t(5;8)(q31;q21) translocation in a patient with mental retardation and congenital heart disease: implications for involvement of RUNX1T1 in human brain and heart development. Eur J Hum Genet 17: 1010-1018.
16. Parakalan R, Jiang B, Nimmi B, Janani M, Jayapal M, et al. (2012) Transcriptome analysis of amoeboid and ramified microglia isolated from the corpus callosum of rat brain. BMC Neurosci 13: 64.
17. Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, et al. (1998) Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 18: 7185-7191. (Pubitemid 28533038)
18. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, et al. (1998) ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 18: 7176-7184. (Pubitemid 28533037)
19. Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM (1998) ETO, fusion partner in t (8; 21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proceedings of the National Academy of Sciences 95: 10860-10865. (Pubitemid 28413159)
20. Mathew OP, Ranganna K, Yatsu FM (2010) Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells. Biomed Pharmacother 64: 733-740.
21. Baumann P, Junghanns C, Mandl-Weber S, Strobl S, Oduncu F, et al. (2012) The pan-histone deacetylase inhibitor CR2408 disrupts cell cycle progression, diminishes proliferation and causes apoptosis in multiple myeloma cells. Br J Haematol 156: 633-642.
22. Zielinska M, Ruszkiewicz J, Hilgier W, Fresko I, Albrecht J (2011) Hyperammonemia increases the expression and activity of the glutamine/arginine transporter y+ LAT2 in rat cerebral cortex: implications for the nitric oxide/cGMP pathway. Neurochem Int 58: 190-195.
23. Closs EI, Boissel JP, Habermeier A, Rotmann A (2006) Structure and function of cationic amino acid transporters (CATs). J Membr Biol 213: 67-77. (Pubitemid 46626126)
24. Nicholson B, Manner CK, Kleeman J, MacLeod CL (2001) Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. Journal of Biological Chemistry 276: 15881-15885.
25. Saura J, Tusell JM, Serratosa J (2003) High-yield isolation of murine microglia by mild trypsinization. Glia 44: 183-189. (Pubitemid 37484470)
26. Huo Y, Rangarajan P, Ling E-A, Dheen ST (2011) Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC neuroscience 12: 49.
27. Nayak D, Huo Y, Kwang W, Pushparaj P, Kumar S, et al. (2010) Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience 166: 132-144.
28. Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, et al. (1992) An immortalized cell line expresses properties of activated microglial cells. Journal of neuroscience research 31: 616-621.
29. Hagopian HK, Riggs MG, Swartz LA, Ingram VM (1977) Effect of n-butyrate on DNA synthesis in chick fibroblasts and HeLa cells. Cell 12: 855-860. (Pubitemid 8224424)
30. Nakamura Y, Si Q, Kataoka K (1999) Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide. Neuroscience research 35: 95-100. (Pubitemid 29518400)
31. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
32. Zhou Q, Dalgard CL, Wynder C, Doughty ML (2011) Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells. BMC Neurosci 12: 50.
33. Abdanipour A, Schluesener HJ, Tiraihi T (2012) Effects of valproic acid, a histone deacetylase inhibitor, on improvement of locomotor function in rat spinal cord injury based on epigenetic science. Iranian biomedical journal 16: 90-100.
34. Kaur C, Dheen ST, Ling EA (2007) From blood to brain: amoeboid microglial cell, a nascent macrophage and its functions in developing brain. Acta Pharmacol Sin 28: 1087-1096. (Pubitemid 47197788)
35. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends in Neurosciences 19: 312-318.
36. Oakford PC, James SR, Qadi A, West AC, Ray SN, et al. (2010) Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1. Leuk Res 34: 1203-1213.
37. Kouzarides T (1999) Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 9: 40-48.
38. Faraco G, Pittelli M, Cavone L, Fossati S, Porcu M, et al. (2009) Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Neurobiol Dis 36: 269-279.
39. Ferreira R, Naguibneva I, Mathieu M, Ait-Si-Ali S, Robin P, et al. (2001) Cell cycle-dependent recruitment of HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F target promoter. EMBO Rep 2: 794-799. (Pubitemid 32982747)
40. Korenjak M, Brehm A (2005) E2F-Rb complexes regulating transcription of genes important for differentiation and development. Curr Opin Genet Dev 15: 520-527. (Pubitemid 41262408)
41. Luo RX, Postigo AA, Dean DC (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92: 463-473. (Pubitemid 28101110)
42. Das SK, Hashimoto T, Shimizu K, Yoshida T, Sakai T, et al. (2005) Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1. Biochim Biophys Acta 1726: 328-335. (Pubitemid 41668543)
43. Soliman ML, Puig KL, Combs CK, Rosenberger TA (2012) Acetate reduces microglia inflammatory signaling in vitro. Journal of neurochemistry 123: 555-567.
44. Melnick AM, Westendorf JJ, Polinger A, Carlile GW, Arai S, et al. (2000) The ETO protein disrupted in t (8; 21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Molecular and cellular biology 20: 2075-2086. (Pubitemid 30123823)